During the past decade, Univ. Hospital in Krakow,Pulmonology Clinical Dept conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ. Hospital in Krakow,Pulmonology Clinical Dept" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Univ. Hospital in Krakow,Pulmonology Clinical Dept" are "Asthma" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Univ. Hospital in Krakow,Pulmonology Clinical Dept" in a lesser frequency.

Most popular intervention types in "Univ. Hospital in Krakow,Pulmonology Clinical Dept" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "nintedanib" (1 trials) and "risankizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ. Hospital in Krakow,Pulmonology Clinical Dept" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Univ. Hospital in Krakow,Pulmonology Clinical Dept". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Univ. Hospital in Krakow,Pulmonology Clinical Dept, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Univ. Hospital in Krakow,Pulmonology Clinical Dept, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".